Estudo randomizado | Em mulheres submetidas a cirurgia citorredutora para câncer de ovário, a adição de quimioterapia intraperitoneal hipertérmica não melhorou a progressão livre de doença e a sobrevida geral.

Survival After Hyperthermic Intraperitoneal Chemotherapy and Primary or Interval Cytoreductive Surgery in Ovarian Cancer: A Randomized Clinical Trial – JAMA Surgery

Conteúdos relacionados:

M-A: Secondary cytoreductive surgery in platinum-sensitive recurrent ovarian cancer.

RCT: Cytoreductive surgery for relapsed ovarian cancer.

Guide to enhanced recovery for cancer patients undergoing surgery: ERAS for Patients Undergoing Cytoreductive Surgery with or Without hyperthermic intraperitoneal chemotherapy.